Načítá se...
Hypoxia-inducible plasmid expressing both miSHP-1 and HO-1 for the treatment of ischemic disease
Ischemic heart disease (IHD) is one of the leading causes of death worldwide. Unfortunately, current pharmacological treatments for ischemic heart disease do not reliably prevent the remodeling of the left ventricle and the progression to heart failure. Gene therapy offers a novel means to directly...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3883575/ https://ncbi.nlm.nih.gov/pubmed/23108071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2012.10.014 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|